This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Nov 26;167(11):1269-70.

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials

Eric Wooltorton

PMID: 12451085
PMCID: PMC134141

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials

Eric Wooltorton. CMAJ. 2002.

. 2002 Nov 26;167(11):1269-70.

Author

Eric Wooltorton

PMID: 12451085
PMCID: PMC134141

No abstract available

PubMed Disclaimer

Comment in

Antipsychotic drugs and diabetes.
McIntyre RS. McIntyre RS. CMAJ. 2003 Mar 18;168(6):673. CMAJ. 2003. PMID: 12642417 Free PMC article. No abstract available.

Similar articles

Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.
Smith DA, Beier MT. Smith DA, et al. J Am Med Dir Assoc. 2004 Mar-Apr;5(2):129-32. J Am Med Dir Assoc. 2004. PMID: 15008183 No abstract available.
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. Katz I, et al. Int J Geriatr Psychiatry. 2007 May;22(5):475-84. doi: 10.1002/gps.1792. Int J Geriatr Psychiatry. 2007. PMID: 17471598
Mortality in elderly dementia patients treated with risperidone.
Haupt M, Cruz-Jentoft A, Jeste D. Haupt M, et al. J Clin Psychopharmacol. 2006 Dec;26(6):566-70. doi: 10.1097/01.jcp.0000239796.21826.39. J Clin Psychopharmacol. 2006. PMID: 17110812
[Risperidone].
Zolk O, Thürauf N. Zolk O, et al. Dtsch Med Wochenschr. 2003 Jun 13;128(24):1353-6. doi: 10.1055/s-2003-39970. Dtsch Med Wochenschr. 2003. PMID: 12802745 Review. German. No abstract available.
Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Hennerici MG; PERFORM Study Investigators. Hennerici MG, et al. Cerebrovasc Dis. 2009;27 Suppl 3:28-32. doi: 10.1159/000209263. Epub 2009 May 14. Cerebrovasc Dis. 2009. PMID: 19439938 Review.

See all similar articles

Cited by

Use of antidementia drugs in frontotemporal lobar degeneration.
López-Pousa S, Calvó-Perxas L, Lejarreta S, Cullell M, Meléndez R, Hernández E, Bisbe J, Perkal H, Manzano A, Roig AM, Turró-Garriga O, Vilalta-Franch J, Garre-Olmo J; Registry of Dementias of Girona Study Group (ReDeGi Study Group). López-Pousa S, et al. Am J Alzheimers Dis Other Demen. 2012 Jun;27(4):260-6. doi: 10.1177/1533317512447887. Epub 2012 May 17. Am J Alzheimers Dis Other Demen. 2012. PMID: 22605780 Free PMC article.
[Therapy of dementia with antipsychotics and antidepressives].
Frölich L, Hausner L. Frölich L, et al. Nervenarzt. 2015 Apr;86(4):461-7. doi: 10.1007/s00115-014-4178-4. Nervenarzt. 2015. PMID: 25787724 Review. German.
Alternatives to atypical antipsychotics for the management of dementia-related agitation.
Passmore MJ, Gardner DM, Polak Y, Rabheru K. Passmore MJ, et al. Drugs Aging. 2008;25(5):381-98. doi: 10.2165/00002512-200825050-00003. Drugs Aging. 2008. PMID: 18447403 Review.
Responses and Interventions to Delusions Experienced by Community-Dwelling Older Persons With Dementia.
Cohen-Mansfield J, Golander H. Cohen-Mansfield J, et al. J Geriatr Psychiatry Neurol. 2022 Jul;35(4):627-635. doi: 10.1177/08919887211042937. Epub 2021 Sep 13. J Geriatr Psychiatry Neurol. 2022. PMID: 34510943 Free PMC article.
Head-to-head comparison of the costs of atypical antipsychotics: a systematic review.
Barbui C, Lintas C, Percudani M. Barbui C, et al. CNS Drugs. 2005;19(11):935-50. doi: 10.2165/00023210-200519110-00004. CNS Drugs. 2005. PMID: 16268665

See all "Cited by" articles

References

1. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods of prevalence of dementia. CMAJ 1994;150:899-913. - PMC - PubMed
1. Beers MH. Behavior disorders in dementia. In: The Merck manual of geriatrics. Whitehouse Station (NJ): Merck & Co. Inc.; 2000. p. 371-7.
1. Ballard C, O'Brien J. Treating behavioural disease and psychological signs in Alzheimer's disease. BMJ 1999;319:138-9. - PMC - PubMed
1. Gauthier S. Advances in the pharmacotherapy of Alzheimer's disease. CMAJ 2002;166(5):616-23. - PMC - PubMed
1. Tune LE. Risperidone for the treatment of behavioral and psychological symptoms of dementia. J Clin Psychiatry 2001;62(Suppl 21):29-32. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information